Insider Shareholders with Direct Ownership of Rigel Pharmaceuticals Inc (RIGL)
This section provides a comprehensive overview of the insiders with direct ownership of Rigel Pharmaceuticals Inc (RIGL). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
RIGEL PHARMACEUTICALS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Raul R Rodriguez
CEO, President |
2,032,300 | 170,742 | 239,454 $5.52 Million | 12 |
Feb 05, 2025
Reduced 1.8%
|
| 100,000 | 0 | 102,222 $2.36 Million | 4 |
May 25, 2024
Added 19.65%
|
|
| 100,000 | 0 | 100,000 $2.31 Million | 4 |
May 25, 2024
Added 20.0%
|
|
| 100,000 | 0 | 100,000 $2.31 Million | 4 |
May 25, 2024
Added 20.0%
|
|
| 100,000 | 0 | 100,000 $2.31 Million | 4 |
May 25, 2024
Added 20.0%
|
|
| 81,250 | 0 | 81,250 $1.87 Million | 4 |
May 25, 2024
Added 23.53%
|
|
| 75,000 | 0 | 75,000 $1.73 Million | 3 |
May 26, 2023
Added 25.0%
|
|
|
Wolfgang Dummer
EVP & CMO |
50,000 | 5,389 | 72,459 $1.67 Million | 2 |
Feb 02, 2023
Reduced 6.92%
|
| 68,750 | 0 | 68,750 $1.59 Million | 3 |
May 25, 2024
Added 26.67%
|
|
|
Dolly Vance
EVP Corp. Affairs, G.C., Sect. |
50,000 | 0 | 60,260 $1.39 Million | 1 |
Jan 24, 2022
Added 45.35%
|
|
Dean L Schorno
EVP & Chief Financial Officer |
341,717 | 21,787 | 57,235 $1.32 Million | 9 |
Feb 05, 2025
Reduced 2.94%
|
|
David A Santos
EVP, Chief Commercial Officer |
358,717 | 23,828 | 51,704 $1.19 Million | 9 |
Feb 05, 2025
Reduced 3.36%
|
|
Raymond J. Furey
EVP, GC, CCO & Corp Sec |
228,717 | 2,787 | 38,830 $895,419 | 4 |
Feb 05, 2025
Reduced 3.33%
|
|
Bradford S Goodwin
Director |
25,000 | 0 | 35,000 $807,100 | 1 |
May 19, 2021
Added 41.67%
|
|
Keith Katkin
Director |
25,000 | 0 | 25,000 $576,500 | 1 |
May 19, 2021
Added 50.0%
|
|
Lisa Rojkjaer
EVP, Chief Medical Officer |
19,717 | 0 | 19,717 $454,674 | 1 |
Jan 29, 2025
Added 50.0%
|